China · State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)
梧州黄埔化工药业有限公司等3家企业
Why it is here
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (江苏省市场监管局 · 市场监管总局发布梧州黄埔化工药业有限公司等3家企业达成并实施垄断协议案行政处罚决定书), from 16 July 2021.
State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).
Details
- Company
- 梧州黄埔化工药业有限公司等3家企业
- Authority
- State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)
- Decision
- Cartel (monopoly agreement)
- Grounds and details, as published
- 江苏省市场监管局 · 市场监管总局发布梧州黄埔化工药业有限公司等3家企业达成并实施垄断协议案行政处罚决定书
- From
- 16 July 2021
- Until
- —
- Status
- End date not published
- Source
- https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_27f20529722e4b11890a64bec488906f.html
- Licence
- Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)
SourceState Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) · Cartel (monopoly agreement)